This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process.

It addresses key aspects of preclinical drug evaluation through the study of:

• Drug discovery and development
• Safety pharmacology
• Mechanisms of drug-induced toxicities
• Regulatory affairs
• Bioanalytical sciences

It will give you state-of-the-art training in preclinical toxicology, with an emphasis on the molecular in vitro and in vivo aspects of toxicology and safety pharmacology assessments.

As part of the programme you will undertake an original research project that will be the basis of your dissertation.

Delivered at the Institute of Cancer Therapeutics, an internationally renowned research institution, the programme gives you the skills you need for a career in the pharmaceutical industry or regulatory bodies, along with the foundations for PhD study.

Drug toxicology and safety pharmacology lies at the heart of the chemical and pharmaceutical industries, and demand for highly skilled practitioners in this field is extremely high.

The largest destination of our graduates is enrolment in PhD studies (47%) including here at Bradford, as well as King’s College London, Cambridge, Manchester, Liverpool, Leeds, Newcastle, Portsmouth and Sheffield.

Career destination of our graduates include the NHS, Covance, Envigo, St James Hospital Leeds, Cyprotex, Chiltern, Perrigo, Dewsbury & District Hospital, Liverpool Institute of Translational Medicine, and Public Health England.